| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
29,794 |
25,575 |
$2.62M |
| 99199 |
Unlisted special service, procedure or report |
309,781 |
150,119 |
$1.51M |
| 99215 |
Prolong outpt/office vis |
6,592 |
5,609 |
$797K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,763 |
10,001 |
$703K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
7,256 |
6,380 |
$608K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
7,105 |
6,173 |
$587K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
6,769 |
5,621 |
$551K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
3,563 |
2,952 |
$464K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
4,877 |
4,165 |
$439K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
19,588 |
17,030 |
$358K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
11,636 |
10,188 |
$258K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
6,170 |
5,562 |
$178K |
| D0145 |
Oral evaluation for a patient under three years of age |
4,484 |
4,063 |
$144K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,780 |
2,086 |
$117K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,397 |
1,324 |
$89K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
9,527 |
8,361 |
$73K |
| D1206 |
Topical application of fluoride varnish |
4,566 |
4,107 |
$64K |
| 99051 |
|
2,483 |
2,262 |
$58K |
| 96160 |
|
12,880 |
10,494 |
$39K |
| 99070 |
|
5,265 |
4,678 |
$28K |
| 90474 |
|
1,839 |
1,644 |
$24K |
| 99442 |
|
469 |
432 |
$18K |
| 99441 |
|
984 |
830 |
$17K |
| 92551 |
|
15,797 |
13,680 |
$12K |
| 90734 |
|
867 |
763 |
$10K |
| 90649 |
|
630 |
547 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
698 |
670 |
$10K |
| 99381 |
|
61 |
55 |
$5K |
| 87634 |
|
190 |
155 |
$5K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
215 |
205 |
$4K |
| 96127 |
|
984 |
958 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
285 |
142 |
$4K |
| 90651 |
|
534 |
439 |
$3K |
| 99173 |
|
17,000 |
14,772 |
$3K |
| 99443 |
|
27 |
25 |
$2K |
| 69210 |
|
44 |
41 |
$2K |
| 90670 |
|
3,844 |
3,417 |
$2K |
| 83655 |
|
99 |
85 |
$1K |
| 96161 |
|
469 |
326 |
$1K |
| 90688 |
|
2,962 |
2,553 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
38 |
31 |
$792.48 |
| 90697 |
|
406 |
337 |
$693.60 |
| 90715 |
|
185 |
160 |
$673.95 |
| 90621 |
|
157 |
136 |
$673.85 |
| 90680 |
|
1,837 |
1,645 |
$554.64 |
| 90461 |
|
42 |
40 |
$338.80 |
| 90633 |
|
1,771 |
1,650 |
$232.48 |
| 85018 |
|
125 |
101 |
$215.41 |
| 90658 |
|
1,647 |
1,478 |
$201.92 |
| 82570 |
|
20 |
13 |
$96.63 |
| 81025 |
|
18 |
13 |
$81.90 |
| 81003 |
|
20 |
13 |
$33.24 |
| 90671 |
|
359 |
312 |
$0.01 |
| 90698 |
|
51 |
50 |
$0.00 |
| 90677 |
|
375 |
366 |
$0.00 |
| 90647 |
|
1,667 |
1,589 |
$0.00 |
| 90696 |
|
168 |
139 |
$0.00 |
| 90657 |
|
466 |
451 |
$0.00 |
| 90723 |
|
638 |
615 |
$0.00 |
| 90619 |
|
176 |
157 |
$0.00 |
| 94760 |
|
14 |
13 |
$0.00 |
| 87428 |
|
13 |
12 |
$0.00 |
| 90710 |
|
1,383 |
1,232 |
$0.00 |
| 90687 |
|
367 |
334 |
$0.00 |
| 90700 |
|
100 |
99 |
$0.00 |